InsidersTradesSigma
申报总数
公司
▲ 买入（4 笔）
▼ 卖出（0 笔）
内部人交易记录
其他已披露买入
4
已披露卖出
0
T+90 胜率
50%
T+90 平均收益
-11.0%
基于 2 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Discover the full record of transactions filed by AI Day1 LLC. Officer active across 1 company, notably Day One Biopharmaceuticals, Inc.. Cumulatively, 6 filings have been logged. Breakdown: 4 buys · 0 sell. Total volume traded: €36.4m. Activity tracked since 18 January 2022. The latest transaction was disclosed on 23 April 2026 (U). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to AI Day1 LLC
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报6 总计
12,929,322 股@ US$21.5028.35% mcap86.6% 占其流量Common StockSEC:0001193125-26-182440:0
979,667 股@ US$10.207625.7% 占其流量Common StockSEC:0001209191-23-053235:0
标准退出：2024年1月16日 (T+90)
769,230 股@ US$13.0025.1% 占其流量Common StockSEC:0001209191-23-036242:0
标准退出：2023年9月7日 (T+90)
1,200,000 股@ US$15.001.78% mcap94.0% 占其流量Common StockSEC:0001209191-22-038431:0
标准退出：2022年9月15日 (T+90)
43,429 股@ US$14.26160.2% 占其流量Common StockSEC:0001209191-22-004174:0
标准退出：2022年4月18日 (T+90)
8,502,776 股Common StockSEC:0001209191-21-037697:0
6 条申报中的 6 条
About AI Day1 LLC
AI Day1 LLC is a declarant linked to Day One Biopharmaceuticals, Inc. (XNAS). The record has 5 filings in total, and across the 5 sampled filings between 2022-01-20 and 2023-10-20, the transactions are acquisitions for EUR 36915438 in total and no sales are reported.
